Evidence map›Paper›PMID 34253611›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Telomere dysfunction instigates inflammation in inflammatory bowel disease.

Deepavali Chakravarti, Rumi Lee, Asha S Multani, Andrea Santoni, Zachery Keith, Wen-Hao Hsu, Kyle Chang, Laura Reyes, Asif Rashid, Chang-Jiun Wu and 19 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Challenges and opportunities in inflammatory bowel disease: from current therapeutic strategies to organoid-based models.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  17. Article
  18. Humanization of the mouseResearch square · 2024
    Article
  19. Rapid Remission With Upadacitinib in a Child With Refractory Crohn's Disease andCurrent therapeutic research, clinical and experimental · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 5 institutions in 2 countries.

Deepavali ChakravartiDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Rumi LeeDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Asha S MultaniDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Andrea SantoniDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Zachery KeithDepartment of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0001-5502-3427
Wen-Hao HsuDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Kyle ChangDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-5295-9676
Laura ReyesDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Asif RashidDivision of Pathology/Lab Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Chang-Jiun WuDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Jun LiDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Jiexin ZhangDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-9526-6730
Hong Seok ShimDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-1024-5920
Krishna ChandraDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-3298-5487
Pingna DengDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Denise J SpringDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-4593-0901
Ole Haagen NielsenDepartment of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev DK-2730, Denmark.ORCID 0000-0003-4612-8635
Lene Buhl RiisDepartment of Pathology, Herlev Hospital, University of Copenhagen, Herlev DK-2730, Denmark.
Kavya Kelagere MayigegowdaDepartment of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, McGovern Medical School and Memorial Hermann Hospital-Texas Medical Center, Houston, TX 77030.
Sarah E BluttDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0002-4062-709X
Jianhua ZhangDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Mamoun YounesDepartment of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, McGovern Medical School and Memorial Hermann Hospital-Texas Medical Center, Houston, TX 77030.ORCID 0000-0001-9618-3451
Andrew DuPontDivision of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Selvi ThirumurthiDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Eduardo VilarDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Mary K EstesDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0002-4813-4249
Simona CollaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0001-6583-8910
Noah F ShroyerDepartment of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0002-5934-2852
Ronald A DePinhoDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; rdepinho@mdanderson.org.ORCID 0000-0002-5625-577X
The University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · USMemorial Hermann · USUniversity of Copenhagen · DKThe University of Texas Health Science Center at Houston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
TELOMERASE IN DEVELOPMENT, SENESCENCE AND NEOPLASIAR01CA084628 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DEPINHO, RONALD ANTHONY · 2000 to 2019
$10.5M
Mechanisms of intestinal stem cell differentiation and plasticity.R01DK118904 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI SHROYER, NOAH FREEMAN · 2018 to 2020
$1.7M
Training Grant in Cancer BiologyT32CA186892 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KALLURI, RAGHU · 2016 to 2020
$1.1M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA084628NCI NIH HHS T32 CA186892NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK118904
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory condition driven by diverse genetic and nongenetic programs that converge to disrupt immune homeostasis in the intestine. We have reported that, in murine intestinal epithelium with telomere dysfunction, DNA damage-induced activation of ataxia-telangiectasia mutated (ATM) results in ATM-mediated phosphorylation and activation of the YAP1 transcriptional coactivator, which in turn up-regulates pro-IL-18, a pivotal immune regulator in IBD pathogenesis. Moreover, individuals with germline defects in telomere maintenance genes experience increased occurrence of intestinal inflammation and show activation of the ATM/YAP1/pro-IL-18 pathway in the intestinal epithelium. Here, we sought to determine the relevance of the ATM/YAP1/pro-IL-18 pathway as a potential driver of IBD, particularly older-onset IBD. Analysis of intestinal biopsy specimens and organoids from older-onset IBD patients documented the presence of telomere dysfunction and activation of the ATM/YAP1/precursor of interleukin 18 (pro-IL-18) pathway in the intestinal epithelium. Employing intestinal organoids from healthy individuals, we demonstrated that experimental induction of telomere dysfunction activates this inflammatory pathway. In organoid models from ulcerative colitis and Crohn's disease patients, pharmacological interventions of telomerase reactivation, suppression of DNA damage signaling, or YAP1 inhibition reduced pro-IL-18 production. Together, these findings support a model wherein telomere dysfunction in the intestinal epithelium can initiate the inflammatory process in IBD, pointing to therapeutic interventions for this disease.

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsHumansInflammatory Bowel DiseasesInterleukin-18Intestinal MucosaMiceTelomeraseTelomereYAP-Signaling ProteinsAtaxia Telangiectasia Mutated ProteinsIL18 protein, humanInterleukin-18TelomeraseYAP1 protein, humanYAP-Signaling ProteinsDNA damageinflammatory bowel diseasepro-IL-18telomere dysfunctionYap1

Identifiers

PMID34253611
PMCPMC8307535
OpenAlexW3181307037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.